'Dabigatran etexilate' presentation slideshows

New Anticoagulant Therapy

New Anticoagulant Therapy. William O. Howe, M.D., FACC The Heart Center of Southern Arizona. Background. Until recently, vitamin K antagonists (VKAs) were the only available orally active anticoagulants. VKAs have numerous limitations, which complicate their use.

646 views • 47 slides

New Anticoagulant Therapy

New Anticoagulant Therapy. William O. Howe, M.D., FACC The Heart Center of Southern Arizona. Background. Until recently, vitamin K antagonists (VKAs) were the only available orally active anticoagulants. VKAs have numerous limitations, which complicate their use.

736 views • 47 slides

Advancements In Anticoagulation

615 views • 42 slides

The case for switching to the emerging oral anticoagulants in Atrial Fibrillation

The case for switching to the emerging oral anticoagulants in Atrial Fibrillation. Dr Neil Baldwin Consultant Physician & Clinical Lead for Stroke North Bristol NHS Trust Bristol neil.baldwin@nbt.nhs.uk. AF prevalence increases with age. 9. 8. 7. 6. 5. AF prevalence (%). 4. 3. 2.

589 views • 42 slides

667 views • 34 slides

Genetic determinants of dabigatran plasma levels and their relation to bleeding

Genetic determinants of dabigatran plasma levels and their relation to bleeding. Guillaume Pare MD.

146 views • 14 slides

Dabigatran Etexilate Market Sales Industry Will Gain Demand in International Market Till 2022

The Dabigatran Etexilate Market report is strategically insightful for both new industry Entrants and Established Players and will help them gauge the pulse of the market which in turn will result in them garners a greater market share. Global Dabigatran Etexilate Industry is a new research report added by Orian Research with figures as recent as 2017 and forecasts up to 2022 that helps you track the unprecedented growth seen in the healthcare and pharma industry giving you an edge to not just compete but to outmatch the competition. The Dabigatran Etexilate Market report is a compilation of the several factors driving and restraining this market along with a thorough run-down of the sales volume of each product within carefully categorized sub-segments of the market.

84 views • 5 slides

Dabigatran Etexilate Market Sales Industry Will Gain Demand in International Market Till 2022

The Dabigatran Etexilate Market report is strategically insightful for both new industry Entrants and Established Players and will help them gauge the pulse of the market which in turn will result in them garners a greater market share. Global Dabigatran Etexilate Industry is a new research report added by Orian Research with figures as recent as 2017 and forecasts up to 2022 that helps you track the unprecedented growth seen in the healthcare and pharma industry giving you an edge to not just compete but to outmatch the competition. The Dabigatran Etexilate Market report is a compilation of the several factors driving and restraining this market along with a thorough run-down of the sales volume of each product within carefully categorized sub-segments of the market.

92 views • 5 slides